DEME signs agreement to acquire Norwegian offshore wind infrastructure company Havfram

April 9, 2025

DEME (Euronext: DEME) announced today that it has signed an agreement to acquire Havfram, an international offshore wind contractor based in Norway. This strategic acquisition aligns with DEME’s ambition to expand its footprint in the offshore wind energy market and enhances its competitive positioning in turbine and foundation installations.

Attachment

P2025 DEME Project Havfram v20250409 ENG

Hot this week

Topics

Popular Categories

News RoomFeatured CompaniesVideos

AMG Approves US Chrome Manufacturing Plant

OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025

DEME signs agreement to acquire Norwegian offshore wind infrastructure company Havfram

Magnera Reports Second Quarter Results – Provides Updated Outlook

Nokia Corporation – Managers’ transactions (Ihamuotila)

Checkpoint Partners Maintains ‘Buy’ Rating and €4 Price Target for Lleida.net

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Topics

Magnera Reports Second Quarter Results – Provides Updated Outlook

Nokia Corporation – Managers’ transactions (Ihamuotila)

Checkpoint Partners Maintains ‘Buy’ Rating and €4 Price Target for Lleida.net

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of April 30, 2025

Result of the auction of 2.25 per cent DGB 2035 and 0.25 per cent DGB 2052

HighCo: Shareholding as 04/30/2025

Related Articles

Magnera Reports Second Quarter Results – Provides Updated Outlook

Nokia Corporation – Managers’ transactions (Ihamuotila)

Checkpoint Partners Maintains ‘Buy’ Rating and €4 Price Target for Lleida.net

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Company

Headlines

Magnera Reports Second Quarter Results – Provides Updated Outlook

Nokia Corporation – Managers’ transactions (Ihamuotila)

Checkpoint Partners Maintains ‘Buy’ Rating and €4 Price Target for Lleida.net

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025

Newsletter